A partnership between Virginia Tech’s Global Change Center and Hollins University will pair distinguished undergraduate students with Virginia Tech professors for a summer of unique research opportunities.
Researchers studying zebrafish have found that genes linked to autism spectrum disorder and other developmental brain abnormalities may be playing a role in people who cannot control their eye movements.
GlaxoSmithKline, a leading global healthcare company, will invest $16.7 million to expand its consumer healthcare research and development center in the City of Richmond.
A doctor at the UVA Children’s Hospital is using a new approach to mapping brain activity to shed light on what happens during seizures in newborns that can lead to behavioral issues and learning disabilities much later.
Virginia Tech has developed a university-wide cancer research strategy to create and expand synergies among more than 30 existing research teams at work finding new ways to prevent, quickly diagnose, and treat cancers, officials announced last week.
Sometimes, the way to take research in a new direction is to bring in a new perspective. That’s the motivation behind the Diversity and Inclusion Seed Investments Program from the Institute for Critical Technology and Applied Science.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.